Considering that a simple dietary intervention meant to reduce saturated fat consumption can dampen MYC transcriptional program, and the recent development of viable MYC inhibitors for therapeutic interventions17,57, we foresee that targeting MYC may help restore a canonical AR transcriptional program and sensitize prostate cancer to AR-targeted therapies. The gene discussed is AR; the disease is prostate cancer.